$FFIV down 19% despite beating earnings and guiding in-line — classic multiple compression, not a fundamental break.
The numbers: revenue up 3.7% vs. Street, FY27 EPS guide matches consensus, estimates barely moved (-0.2%). Four out of five analysts raised price targets post-print. Alphatica's Earnings Quality Score tags this 5/6 bullish. The financials are clean.
So what's the problem? The market's pricing in a refresh-cycle slowdown in H2 and flat deferred revenue. That pushed the forward multiple from 25x down to 20x — a sentiment reset, not a deterioration in the business model.
The setup: this is overdone relative to what the data actually shows. Could it drift lower near-term? Sure. But the risk/reward here tilts toward dip-buying if you're comfortable with the cycle thesis and can stomach some chop. The underlying quality didn't vanish overnight.
The numbers: revenue up 3.7% vs. Street, FY27 EPS guide matches consensus, estimates barely moved (-0.2%). Four out of five analysts raised price targets post-print. Alphatica's Earnings Quality Score tags this 5/6 bullish. The financials are clean.
So what's the problem? The market's pricing in a refresh-cycle slowdown in H2 and flat deferred revenue. That pushed the forward multiple from 25x down to 20x — a sentiment reset, not a deterioration in the business model.
The setup: this is overdone relative to what the data actually shows. Could it drift lower near-term? Sure. But the risk/reward here tilts toward dip-buying if you're comfortable with the cycle thesis and can stomach some chop. The underlying quality didn't vanish overnight.